LTO1 (AA 1-137) protein (His-IF2DI Tag)

Produktnummer ABIN7124267

Dieses Recombinant -Protein wird in Escherichia coli (E. coli) produziert.

Kurzübersicht für LTO1 (AA 1-137) protein (His-IF2DI Tag) (ABIN7124267)

Target: LTO1

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Applikation: ELISA, Western Blotting (WB)

Reinheit: Greater than 90 % as determined by SDS-PAGE.

Produktdetails

Proteineigenschaft: AA 1-137

Aufreinigungstag / Konjugat: His-IF2DI Tag

Verwendungszweck: Recombinant Human LTO1

Sterilität: 0.2 μm filtered

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/mL by gently pipetting 2-3 times, don't vortex.

Buffer: Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: The lyophilized protein is stable at -20 °C for up to 1 year. After reconstitution, the protein solution is stable at -20 to -80 °C for 3 months or 1 week at 2 to 8 °C under sterile conditions. For extended storage, it is recommended to further dilute in working aliquots, avoid repeated freeze/thaw cycle.

Haltbarkeit: 12 months

Antigendetails

Target: LTO1

Hintergrund: Oral cancer overexpressed 1, Oral cancer overexpressed protein 1 A, Oral cancer-overexpressed protein 1, ORAOV1, ORAOV1 oral cancer overexpressed 1, ORAV1_HUMAN, TAOS1, Tumor amplified and overexpressed sequence 1, Tumor-amplified and overexpressed sequence 1

Molekulargewicht: 15 kDa

UniProt: Q8WV07